Trial intelligence / Profile preview

MILES: MSCs vs Corticosteroids for Knee Osteoarthritis

NCT03818737Phase 3Completed

Sponsor
Emory University
Start
Mar 2019
Primary completion
May 2022
Modality
Stem Cell Therapies
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of adipose derived mesenchymal stromal cells and umbilical cord tissue mesenchymal stem cells in osteoarthritis (OA), sponsored by Emory University. Started Mar 2019; status: completed.

02

Drugs

adipose derived mesenchymal stromal cellsumbilical cord tissue mesenchymal stem cells
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03818737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03818737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call